These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8859191

  • 1. A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.
    Small EJ, Fippin LJ, Ernest ML, Carroll PR.
    Cancer; 1996 Oct 15; 78(8):1775-80. PubMed ID: 8859191
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chemotherapy with methotrexate, carboplatin, mitoxantrone (Novantrone) and vincristine (Oncovin) in transitional-cell urothelial cancer.
    Pectasides D, Mylonakis A, Antoniou F, Kostopoulou M, Triantaphyllis D, Papadopoulou M, Varthalitis J, Dimitriadis M, Athanassiou A.
    Oncology; 1998 Oct 15; 55(2):139-44. PubMed ID: 9499188
    [Abstract] [Full Text] [Related]

  • 5. Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.
    Boccardo F, Pace M, Guarneri D, Canobbio L, Curotto A, Martorana G.
    Cancer; 1994 Apr 01; 73(7):1932-6. PubMed ID: 8137220
    [Abstract] [Full Text] [Related]

  • 6. Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation.
    Edelman MJ, Meyers FJ, Miller TR, Williams SG, Gandour-Edwards R, deVere White RW.
    Urology; 2000 Apr 01; 55(4):521-5. PubMed ID: 10736495
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study.
    Tsavaris N, Kosmas C, Skopelitis H, Dimitrakopoulos A, Kopterides P, Bougas D, Stravodimos K, Mitropoulos D, Alamanis C, Giannopoulos A.
    J Chemother; 2005 Aug 01; 17(4):441-8. PubMed ID: 16167525
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Carboplatin, methotrexate, and vinblastine in outpatients with advanced transitional cell carcinoma of the bladder.
    Pronzato P, Landucci M, Vaira F, Vigani A, Bertelli G.
    Am J Clin Oncol; 1995 Jun 01; 18(3):223-5. PubMed ID: 7747710
    [Abstract] [Full Text] [Related]

  • 10. Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group.
    Linardou H, Aravantinos G, Efstathiou E, Kalofonos C, Anagnostopoulos A, Deliveliotis C, Bafaloukos D, Athanasios Dimopoulos M, Bamias A, Phase II study of Hellenic Co-operative Oncology Group.
    Urology; 2004 Sep 01; 64(3):479-84. PubMed ID: 15351574
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study.
    Skarlos DV, Aravantinos G, Linardou E, Kostakopoulos CA, Kastriotis I, Christodoulou C, Picramenos D, Giannakakis T, Dimopoulos K, Fountzilas G.
    Eur Urol; 1997 Sep 01; 31(4):420-7. PubMed ID: 9187901
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of advanced urothelial carcinoma with M-VECA (methotrexate, vinblastine, epirubicin and carboplatin).
    Lorusso V, Pagliarulo A, Selvaggi FP, Durini E, Riccardi F, Comella P, Fiorillo C, De Lena M.
    J Chemother; 1996 Apr 01; 8(2):154-8. PubMed ID: 8708748
    [Abstract] [Full Text] [Related]

  • 14. CMV front-line chemotherapy in transitional bladder carcinoma.
    Paz-Ares L, Lianes P, Díaz-Puente M, Rivera F, Passas J, Costas P, Mendiola C, Cortés-Funes H.
    Ann Oncol; 1993 Feb 01; 4(2):147-50. PubMed ID: 8448083
    [Abstract] [Full Text] [Related]

  • 15. A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium.
    Xu N, Zhang XC, Xiong JP, Fang WJ, Yu LF, Qian J, Zhang L.
    BMC Cancer; 2007 Jun 09; 7():98. PubMed ID: 17559681
    [Abstract] [Full Text] [Related]

  • 16. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH, Chen J, Wu CY, Cheng AL, Pu YS.
    Anticancer Res; 2001 Jun 09; 21(1B):711-5. PubMed ID: 11299831
    [Abstract] [Full Text] [Related]

  • 17. Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point.
    Small EJ, Lew D, Redman BG, Petrylak DP, Hammond N, Gross HM, Eastham JA, Crawford ED.
    J Clin Oncol; 2000 Jul 09; 18(13):2537-44. PubMed ID: 10893284
    [Abstract] [Full Text] [Related]

  • 18. Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy.
    Nogué-Aliguer M, Carles J, Arrivi A, Juan O, Alonso L, Font A, Mellado B, Garrido P, Sáenz A, Spanish Cooperative Group.
    Cancer; 2003 May 01; 97(9):2180-6. PubMed ID: 12712469
    [Abstract] [Full Text] [Related]

  • 19. Carboplatin, methotrexate, vinblastine and epirubicin (Carbo-MVE) for transitional cell bladder carcinoma.
    Solá C, Mallafré J, Mendoza Solórzano L, Segarra A, Daniels M, Viñolas N, Alcaraz A, Solé M, Alvarez R, Biete A.
    Ann Oncol; 1993 Apr 01; 4(4):313-6. PubMed ID: 8518222
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study.
    Halim A, Abotouk N.
    Asia Pac J Clin Oncol; 2013 Mar 01; 9(1):60-5. PubMed ID: 22897883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.